New Decision-Making Tool Can Cut Unnecessary Antibiotic Use

Share this content:
New Decision-Making Tool Can Cut Unnecessary Antibiotic Use
New Decision-Making Tool Can Cut Unnecessary Antibiotic Use

FRIDAY, Sept. 2, 2016 (HealthDay News) -- A new decision-making tool for doctors may help reduce unnecessary use of antibiotics in children with respiratory tract infection and cough, according to research published online Sept. 1 in The Lancet Respiratory Medicine.

Using information from 8,394 children, the investigators identified seven key predictors that could be used to help determine whether a child with a respiratory tract infection and cough is likely to require antibiotics.

Those predictors are: short illness (less than three days); fever of 100 degrees Fahrenheit or higher; younger than 2 years old; respiratory distress; wheeze; asthma; and moderate/severe vomiting in the previous 24 hours. Children with none, or just one, of these predictors are at very low risk of future complications, the researchers said.

The decision-tool "could reduce clinical uncertainty, and thereby antibiotic use, in children at very low risk of future hospital admission who form the majority of children presenting to primary care with acute respiratory tract infection and cough," the authors write. "If antibiotic prescription in this group halved, remained static in the normal-risk stratum, and increased to 90 percent in the high-risk stratum, a 10 percent overall reduction in antibiotic prescribing would be achieved, similar to other contemporary antimicrobial stewardship interventions."

One author disclosed financial ties to Nanosphere, Hologic, and Sanofi Pasteur

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »